Science Explorer Back to mapMap
Discussion
Company · Sandvika · Norway

AlgiPharma (Norway)

algipharma.com/en/en/home.aspxROR OpenAlex
Research works
14
▼ 69% vs 2018-21
Citations
336
24.6 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
71%
world 40%
International
73%
world 18%
AlgiPharma (Norway)

Not ranked overall: AlgiPharma (Norway) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AlgiPharma (Norway) work in?

In all years, 50% of research at AlgiPharma (Norway) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (19%), Agricultural and Biological Sciences (7%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 49.9% of its workMedicine: 6 fractional works · 42.2% of its workPulmonary and Respiratory Medicine: 4 fractional works · 31.9% of its workPharmacology: 0 fractional works · 2.6% of its workInfectious Diseases: 0 fractional works · 2.3% of its workEpidemiology: 0 fractional works · 2.0% of its workGenetics: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.9% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 6.4% of its workSpeech and Hearing: 1 fractional works · 4.9% of its workEmergency Medical Services: 0 fractional works · 1.5% of its workDentistry: 0 fractional works · 0.8% of its workPeriodontics: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workLife Sciences: 5 fractional works · 34.9% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 18.8% of its workMolecular Biology: 1 fractional works · 10.8% of its workMolecular Medicine: 1 fractional works · 5.3% of its workCell Biology: 0 fractional works · 1.2% of its workBiotechnology: 0 fractional works · 0.8% of its workEndocrinology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 1 fractional works · 7.2% of its workFood Science: 0 fractional works · 2.9% of its workAquatic Science: 0 fractional works · 2.3% of its workPlant Science: 0 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 5.3% of its workPharmaceutical Science: 1 fractional works · 5.3% of its workImmunology and Microbiology: 0 fractional works · 2.8% of its workMicrobiology: 0 fractional works · 2.5% of its workImmunology: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workPhysical Sciences: 2 fractional works · 15.3% of its workEngineering: 1 fractional works · 6.5% of its workElectrical and Electronic Engineering: 1 fractional works · 4.9% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workChemistry: 0 fractional works · 3.1% of its workOrganic Chemistry: 0 fractional works · 3.1% of its workComputer Science: 0 fractional works · 2.4% of its workComputer Vision and Pattern Recognition: 0 fractional works · 2.4% of its workMaterials Science: 0 fractional works · 2.4% of its workBiomaterials: 0 fractional works · 2.4% of its workEnvironmental Science: 0 fractional works · 0.8% of its workPollution: 0 fractional works · 0.8% of its workALL ITS WORKAlgiPharma(Norway)14fractional works, all years
Life Sciences35%Physical Sciences15%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 14 fields, with their numbers
    1. Medicine642.2%
    2. Health Professions16.4%
    3. Dentistry00.8%
    4. Nursing00.4%
    1. Biochemistry, Genetics and Molecular Biology318.8%
    2. Agricultural and Biological Sciences17.2%
    3. Pharmacology, Toxicology and Pharmaceutics15.3%
    4. Immunology and Microbiology02.8%
    5. Neuroscience00.8%
    1. Engineering16.5%
    2. Chemistry03.1%
    3. Computer Science02.4%
    4. Materials Science02.4%
    5. Environmental Science00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 6.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.99× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 35.52× its world share, 0 worksPharmacology, Toxico…Chemistry: 5.48× its world share, 0 worksChemistryHealth Professions: 3.56× its world share, 0 worksHealth ProfessionsMedicine: 0.85× its world share, 0 worksMedicineNursing: 6.39× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 35.5×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics35.52×0 works
  2. Nursing6.39×0 works
  3. Agricultural and Biological Sciences6.06×0 works
  4. Chemistry5.48×0 works
  5. Biochemistry, Genetics and Molecular Biology3.99×0 works
  6. Health Professions3.56×0 works
  7. Medicine0.85×0 works

Who are the top researchers at AlgiPharma (Norway)?

Ranked on the quality score, Edvar Onsøyen and Philip D. Rye lead among researchers whose main affiliation is AlgiPharma (Norway).

  1. 1 Edvar Onsøyen Norway · #1,138,400 worldwide 1.3k citations · 33 works
  2. 2 Philip D. Rye Norway · #2,215,967 worldwide 2.1k citations · 85 works
All ranked researchers at AlgiPharma (Norway)

What are the most cited papers from AlgiPharma (Norway)?

The most cited paper from AlgiPharma (Norway) is "Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides" (Lydia C. Powell, M. Pritchard, Elaine L. Ferguson et al., 2018), with 188 citations. Next come "Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics" (172) and "A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness" (89).

Most cited papers
#PaperReleasedCitations
1 Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides Lydia C. Powell, M. Pritchard, Elaine L. Ferguson et al. · npj Biofilms and Microbiomes Open access 25 Jun 2018 188
2 Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics Saira Saeed Khan, Anne Tøndervik, Håvard Sletta et al. · Antimicrobial Agents and Chemotherapy Open access 24 Jul 2012 172
3 A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness M. Pritchard, Lydia C. Powell, Alison A. Jack et al. · Antimicrobial Agents and Chemotherapy Open access 20 Jun 2017 89
4 Alginate Oligosaccharides Inhibit Fungal Cell Growth and Potentiate the Activity of Antifungals against Candida and Aspergillus spp Anne Tøndervik, Håvard Sletta, Geir Klinkenberg et al. · PLoS ONE Open access 19 Nov 2014 89
5 A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease M. Pritchard, Lydia C. Powell, Georgina Elizabeth Menzies et al. · Molecular Pharmaceutics Open access Feb 2016 85
All 34 most cited papers, with filters and sorting

Which research topics does AlgiPharma (Norway) publish most on?

By volume in 2022-now: Carbohydrate Chemistry and Synthesis, Polysaccharides and Plant Cell Walls, Dysphagia Assessment and Management and Seaweed-derived Bioactive Compounds.

Carbohydrate Chemistry a…0Carbohydrate Chemistry and Synthesis: 0 fractional worksPolysaccharides and Plan…0Polysaccharides and Plant Cell Walls: 0 fractional worksDysphagia Assessment and Management: 0 fractional worksSeaweed-derived Bioactiv…0Seaweed-derived Bioactive Compounds: 0 fractional worksAdvanced Drug Delivery S…0Advanced Drug Delivery Systems: 0 fractional worksCystic Fibrosis Research…0Cystic Fibrosis Research Advances: 0 fractional worksProbiotics and Fermented…0Probiotics and Fermented Foods: 0 fractional worksAntibiotic Resistance in Bacteria: 0 fractional worksMedicinal Plants and Neuroprotection: 0 fractional worksAntifungal resistance and susceptibility: 0 fractional works
Organic ChemistryPlant ScienceSpeech and HearingAquatic Science6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
  2. 2 Polysaccharides and Plant Cell Walls Plant Science 0 works
  3. 3 Dysphagia Assessment and Management Speech and Hearing 0 works
  4. 4 Seaweed-derived Bioactive Compounds Aquatic Science 0 works
  5. 5 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  6. 6 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  7. 7 Probiotics and Fermented Foods Food Science 0 works
  8. 8 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  9. 9 Medicinal Plants and Neuroprotection Complementary and alternative medicine 0 works
  10. 10 Antifungal resistance and susceptibility Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.4%not open28.6%

World: 40% of research is openly available.

with international co-authors73.2%domestic only26.8%

World: 18% is written across borders.

How has AlgiPharma (Norway)'s research output changed?

Output in 2022-2025 was 69% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AlgiPharma (Norway) as a percentage of every work published that year, 0.000011% in 2023.

0.000020%0.000040%0.000060%AlgiPharma (Norway)0.0000052% in 20242020

Fractional works of AlgiPharma (Norway) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Sandvika

All research institutions in Sandvika

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AlgiPharma (Norway). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.